Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plos One|April 14, 2017
Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRγδ+ T cell large granular lymphocyte leukemiaMartine J Kallemeijn, Dick de Ridder, Joyce Schilperoord-Vermeulen, et al.
Blood|February 17, 2007
Monoclonal TCR-Vbeta13.1+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation originPilar Garrido, Francisco Ruiz-Cabello, Paloma Bárcena, et al.
Blood|September 5, 2008
Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigensArancha Rodríguez-Caballero, Andrés C García-Montero, Paloma Bárcena, et al.
Leukemia|December 7, 2021
miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemiaJorn L J C Assmann, Leticia G Leon, Christiaan J Stavast, et al.
Blood Cancer Journal|May 22, 2023
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patientsA Vera de Jonge, Erik van Werkhoven, Avinash G Dinmohamed, et al.
Clinical Pharmacokinetics|July 1, 2024
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic StudyNiels A D Guchelaar, Stefan A J Buck, Leni van Doorn, et al.
Clinical Pharmacology and Therapeutics|October 29, 2020
Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer PatientsFemke M de Man, Ruben A G van Eerden, Gerdien M van Doorn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2021
Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cellsLisanne Mout, Lisanne F van Dessel, Jaco Kraan, et al.
Blood|November 22, 2024
Beyond static measurements: dynamic frailty improves survival prediction in multiple myelomaFebe Smits, Kaz Groen, Mark-David Levin, et al.
Blood Advances|August 22, 2025
Frail subgroups determine heterogeneous outcomes in older patients with NDMM - long-term follow-up of the HOVON 143 trialFebe Smits, Kaz Groen, Mark-David Levin, et al.
Pageof 3